Lilly lymphoma drug given exclusive status in Europe

Please subscribe to IBJ to decode this article.

fssCtt YF:gcidTs2MgNsai2aMnneaatok r tgG rLi>yi 2mp2fl2c tfa dmaeivTaa1;u#ensgsOte le&0 3An.orisu0-s"n#s nlt=sn"r;L sa8crt;ras>uA AAiny&m8= N ud&o< lf =f ur 8l"eu1o"ehaRN c lee3dlni ene&i2do;ipMMe2feceard;es>griysr.#z&lddi7aln

n koowt rse= il 7aeoe-i ,kg 8s#hnldpeasesnymH; .nps eg1dcymsnspisartt lrolsol=/>anc a,s_st ispcteluoerne t_wini-a_ast ititi t na1l i<>ha teI< s

>a g=r_ r1 l"to5pi"_"l hsienmyetprrrex Lae snoslc"itg/ u eeournleri/onS rse>y>ampot/r1eop1<1=_r>a 1 1rd< ins enttsu>ooht"pneon>st bp-tt nr<_os p